Quantifying Effects of Treatment of Pediatric Dysphonia
Voice Disorders, Gastroesophageal Reflux
About this trial
This is an interventional treatment trial for Voice Disorders focused on measuring behavior therapy, combination therapy, gastrointestinal disorder chemotherapy, human therapy evaluation, larynx disorder, middle childhood (6-11), lansoprazole, reflux esophagitis, quality of life, clinical research, human subject, laryngoscopy, patient oriented research, questionnaire
Eligibility Criteria
Inclusion Criteria: chronic dysphonia with suspected extraesophageal reflux Exclusion Criteria: previous reflux treatment. laryngeal disorder treated primarily with surgery
Sites / Locations
- University of Wisconsin
Arms of the Study
Arm 1
Arm 2
Active Comparator
Sham Comparator
Neuromuscular Electrical Stimulation
Unstimulated
Subjects will receice Neuromuscular Electrical Stimulation (NMES)-stimulated swallowing combined with exercise therapy.
Subjects will receive sham (unstimulated) swallow therapy combined with exercise therapy.